Microwave assisted synthesis of dihydrobenzo [4, 5] imidazo [1,2-a] pyrimidin-4-ones; synthesis, in vitro antimicrobial and anticancer activities of novel coumarin substituted dihydrobenzo [4, 5] In general, all the compounds possessed better antifungal properties than antibacterial properties. The coumarin substituted dihydrobenzo [4, 5] imidazo[1,2-a]pyrimidin-4-one (4g) (R ¼ i-Pr, R 1 ¼ 6-Cl) was found to be the most potent cytotoxic compound (88%) against Dalton's Ascitic Lymphoma cell line at the concentration of 100 mg/mL.
Introduction
Dihydrobenzo [4, 5] imidazo[1,2-a]pyrimidin-4-one is a class of fused tricyclic system having three nitrogen atoms. The design concept of dihydrobenzo [4, 5] imidazo[1,2-a]pyrimidin-4-ones has arised from the broad spectrum and the wide range of biological activities of the benzimidazole and pyrimidine.
Benzimidazole derivatives [1] exhibited high cytotoxicity against HepG-2 cells and good EGFR inhibitory activity. 2-Substituted-5-amino-benzimidazoles [2] possessed significant cytotoxicity against breast cancer cell line MCF-7. 1,2,5-Trisubstituted benzimidazoles [3] and benzimidazolo pyrimidine conjugates [4] were found to be antitumor agents against Melanoma cell lines. QSAR analyses of 2-aminobenzimidazole derivatives [5] were studied on the relation between acute toxicity and the octanol/water partition coefficient.
6-Butylfuro [2,3-d] pyrimidine derivatives [6] showed the highest cytostatic activity against Malignant leukemia and T-lymphocyte cells. 5-Benzylidine barbiturate derivatives [7] inhibited the growth of mushroom tyrosinase and Gram-positive bacteria Staphylococcus aureus. Pyrimidine bases [8] exerted pronounced antiproliferative activity against the HeLa and MiaPaCa-2 cell lines. 1-Adamantyl thiopyrimidines [9] displayed the significant cytotoxic activity particularly against H69AR cell line. Pyrimidine analogs of indane-1,3-diones [10] showed significant reduction in ulcerogenic activity when compared to standard drug Indomethacin.
The fusion of benzimidazole and pyrimidine pharmacophores in a single molecular frame work and the study of subsequent influence on the biological activities are of current interest.
The known synthetic method of dihydrobenzo [4, 5] imidazo[1,2-a]pyrimidin-4-one derivatives [11] had many demerits such as long reaction time, drastic condition, tedious experimental procedure and low yield. Hence, there is a need for a simple and straight forward method for the synthesis of dihydrobenzo [4, 5] imidazo [1,2-a]pyrimidin-4-one derivatives. On the otherhand, to date, neither the synthesis nor the biological evaluation of dihydrobenzo [4, 5] imidazo[1,2-a]pyrimidin-4-ones has been reported in the literature. For all these reasons, we have done laboratory work on the synthesis of fused dihydrobenzo [4, 5] imidazo[1,2-a]pyrimidin-4-ones.
Coumarins are known to be biologically versatile compounds possessing several biological properties. Coumarin Mannich bases [12] inhibited carraggeenin-induced hind paw edema and found to possess protective properties against adjuvant-induced arthritis in rats. 4-Amino-3-(2-methylbenzyl)coumarin derivatives [13] exhibited potent estrogenic activity on the estrogen receptor positive (ER þ ) human MCF-7 breast cancer cell line. 4-Hydroxy coumarin derivatives [14] showed pronounced prolongation of prothrombin time with anticoagulant values similar to that of warfarin. Benzothiazolyl coumarin acetamide derivatives [15] exhibited strong in vitro anti-HIV effect against the wild-type HIV-1 cell line. The in vitro antioxidant activities of 4-schiff bases-7-benzyloxy coumarin derivatives [16] revealed that DPPH and ABTS þ radical scavenging activities were better than that of the commercial antioxidant BHT.
Based on the survey of recent literature studies on benzimidazoles, pyrimidines and coumarins and in our effort to discover novel antimicrobial and anticancer agents, the aim of our work is synthesis of coumarin substituted dihydrobenzo [4, 5] imidazo[1,2-a]pyrimidin-4-ones and to evaluate them for their therapeutic importance.
Chemistry
The synthesis of compounds (2aeh) (R: a; i-Pr, b; 4-CF 3 C 6 H 4 , c; 3-FC 6 H 4 , d; CF 3, e; C 6 H 5 , f; 4-FC 6 H 4 , g; 3-ClC 6 H 4 , h; 4-CH 3 OC 6 H 4 ) was accomplished by synthetic sequence shown in Scheme 1. The preparation of dihydrobenzo [4, 5] imidazo[1,2-a]pyrimidin-4-ones was carried out by the condensation of b-ketoesters (1aeh) with 2-aminobenzimidazole under microwave irradiation. The best conditions to obtain these compounds were achieved at 130 C using DMF as a reaction media. This method gave the higher yield (74e94%) and required a shorter reaction time (3 min). The compounds (2deh) have already been reported by the thermal method (Table 1 ) in the literature [11] .
4-Bromomethyl coumarins [17] (3aef) were synthesized by Pechmann cyclization of phenols with 4-bromoethylacetoacetate [18] using conc. H 2 SO 4 as a cyclizing agent. The synthesis of coumarin substituted dihydrobenzo [4, 5] imidazo[1,2-a]pyrimidin-4-ones (Scheme 2) were carried out by reaction of 4-bromomethyl coumarins (3aef) (R 1 ¼ a; 6-OMe, b; 6-F, c; 6-CH 3 , d; 6,8-dimethyl, e; 6-Cl, f; 6-Br) with dihydrobenzo [4, 5] imidazo[1,2-a]pyrimidin-4-ones (2a, b) (R ¼ a; i-Pr, b; 4-CF 3 C 6 H 4 ) in the presence of anhydrous K 2 CO 3 in dry acetone at room temperature for 24 h. Removal of solvents under reduced pressure afforded the title compounds (4aeh) as solids which were purified by routine methods. The numbering of the skeleton is shown in Fig. 1 .
Result and discussion
In the IR spectrum of the compound 2-isopropyl-10H-benzo [4, 5] C NMR spectral data of all the compounds is given in Experimental section.
The IR spectrum of the compound 10-(6-methoxy-2-oxo-2H-chromen-4-ylmethyl)-2-trifluoromethyl-10H-benzo [4, 5] Synthesis of reported compounds (2deh) under microwave irradiation.
The molecular structure of the compound (4b) is also established by single crystal analysis [19] as shown in Fig. 2 .
Antimicrobial activity
All the newly synthesized compounds (2aeh) and (4aeh) were screened for their antibacterial and antifungal activity at different concentrations of 100, 50, 25, 12.5, 6.25, 3.125, 1.6, 0.8, 0.4 and 0.2 mg/mL by the broth micro dilution method. The minimum inhibitory concentrations (MIC) were determined by serial dilution method [20] .
Antibacterial activity was carried out against three Grampositive bacteria viz., Staphylococcus. aureus, Enterococcus faecalis, Streptococcus mutans and three Gram-negative bacteria viz., Escherichia coli, Klebsiella pneumonia and Pseudomonas aeruginosa. Ciprofloxacin was used as a standard. Antifungal activity was carried out against six fungi viz., Candida albicans, Aspergillus niger, Aspergillus fumigatus, Aspergillus flavus, Fusarium oxysporum and Penicillium chrysogenum. Fluconazole was used as a standard.
The investigation of antibacterial data (Table 2) showed that most of the tested compounds exhibited good bacterial inhibition. The compounds (2aeh) were found to be highly active against E. faecalis with MIC of 0.2 mg/mL. The compound (4d) (R ¼ CF 3 , R 1 ¼ 6,8-dimethyl) was found to be highly active against S. mutans with MIC of 0.2 mg/mL. The compound (4e) (R ¼ i-Pr, R 1 ¼ 6-F) was found to be most active against S. mutans with MIC of 0.8 mg/mL (Fig. 3) . It is interesting to note that all the tested compounds were found to be most potent against E. faecalis when compared to standard drug Ciprofloxacin. The rest of the compounds were found to be inactive.
The investigation of antifungal data (Table 3) showed that most of the tested compounds exhibited good fungal inhibition. The compounds (2f) (R ¼ 4-FC 6 H 4 ) and (2g) (R ¼ 4-ClC 6 H 4 ) were found to be highly active against A. fumigatus and A. flavus with MIC of
and (4aeh) were found to be highly active against F. oxysporum with
were found to be highly active against P. chrysogenum with MIC of 0.2 mg/mL (Fig. 4) . It is interesting to note that all the tested compounds were found to be most potent against A. fumigatus, F. oxysporum and P. chrysogenum when compared to standard drug Fluconazole.
In vitro cell cytotoxicity
The newly synthesized compounds (2aeh) and (4aeh) were determined in vitro cell cytotoxicity by using trypan blue dye exclusion assay method [21] . In this test, only the dead cells took up the dye due to lack of intact membranes. Dalton's Ascitic Lymphoma (DAL) cells (0.2 mL, 10 6 cells/mL), ice cold phosphate buffer saline (1 mL, p H ¼ 7.4) and one of the compounds (2aeh) and (4ae h) (0.2 mL) were taken in an Eppendorf tube. They were incubated in CO 2 incubator at 37 C with continuous flow of 5% CO 2 for 3 h. The investigation of in vitro cell cytotoxicity (Table 4) revealed that most of the tested compounds exhibited good activity. The
and (4g) (R ¼ iPr, R 1 ¼ 6-Cl) were found to be highly active (>70%) against DAL cell at the concentration of 100 mg/mL. The rest of the compounds were found to be moderately active (>40%) against DAL cell at the concentration of 100 mg/mL (Fig. 5 ).
Experimental section
The melting points were determined by open capillary method using electric melting point apparatus and are uncorrected. The IR spectra (KBr disc) were recorded on a Shimadzu-8400S FT-IR Spectrophotometer.
1 H NMR spectra were recorded on Bruker 300 MHz spectrometer. 13 was added to a microwave tube equipped with a magnetic stir bar. The microwave tube was fitted with a reflux condenser and irradiated in a microwave reactor at a temperature of 130 C for 3 min Fig. 3 . Antibacterial activity of compounds (2aeh) and (4aeh).
Tested compounds
at a maximum power of 320 W. Then, the reaction mixture was poured on to crushed ice. The solid was filtered and washed with 100 mL of cold water. The crude product was dried and recrystallized from 1:3 ethyl acetate and chloroform. stirring was continued for 24 h. The reaction mixture was concentrated to one fourth volume and poured on to crushed ice. The solid separated was filtered and washed with 5% HCl (10 mL). Then, it was washed with 50 mL of cold water. The crude product was dried and recrystallized from ethanol.
3.1.2.1. 10-(6-Methoxy-2-oxo-2H-chromen-4-ylmethyl)-2-trifluoromethyl-10H-benzo [4, 5] imidazo 
Conclusion
In conclusions, we have developed a simple method for the synthesis of dihydrobenzo [4, 5] imidazo[1,2-a]pyrimidin-4-ones under microwave irradiation giving excellent yields of the products (74e94%) in shorter reaction time (3 min). These molecules further reacted with various substituted 4-bromomethylcoumarins to yield a new series of coumarin substituted dihydrobenzo [4, 5] imidazo [1,2-a]pyrimidin-4-ones. The in vitro antimicrobial screening revealed that all the tested compounds possessed better antifungal properties than antibacterial properties. The coumarin substituted dihydrobenzo [4, 5] imidazo[1,2-a]pyrimidin-4-one (4g) (R ¼ i-Pr, R 1 ¼ 6-Cl) was found to be the most potent cytotoxic compound (88%) against Dalton's Ascitic Lymphoma cell line at the concentration of 100 mg/mL.
